Plunkett Research Online: Mersana Therapeutics

MERSANA THERAPEUTICS (MRSN) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company using its differentiated and proprietary ADC platforms to develop targeted drugs with increased tolerability and expanded opportunities to deliver meaningful clinical benefit to patients. The Company's early stage programs includ.....


MERSANA THERAPEUTICS

Ticker: MRSN
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 617 498-0020
Fax:
Address: 840 Memorial Drive
Cambridge, MA 02139 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Martin HuberCEO/Director/President
Brian DeSchuytnerCFO/COO/Senior VP
See More
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company using its differentiated and proprietary ADC platforms to develop targeted drugs with increased tolerability and expanded opportunities to deliver meaningful clinical benefit to patients. The Company's early stage programs includ.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture